Zachariah Chowdhury | Medicine and Dentistry | Best Researcher Award

Posted on by Shen Awards

Dr. Zachariah Chowdhury | Medicine and Dentistry | Best Researcher Award

Professor, Dept Of Oncopathology from Mahamana Pandit Madan Mohan Malviya Cancer Centre (Tata Memorial Hospital) Varanasi, India

Dr. Zachariah Chowdhury is an accomplished academician, clinician, and researcher in the field of oncopathology, currently serving as the Professor and Officer-in-Charge of the Department of OncoPathology at the Mahamana Pandit Madan Mohan Malaviya Cancer Centre (MPMMCC) & Homi Bhabha Cancer Hospital (HBCH) in Varanasi, under the Tata Memorial Centre. With foundational training in MBBS and MD in Pathology from Assam Medical College and a UICC Fellowship in Oncopathology, he has demonstrated an unwavering commitment to excellence in pathology and cancer diagnostics. His extensive teaching background includes instruction at multiple academic levels, including DM, MD, MBBS, nursing, and laboratory technology programs. Dr. Chowdhury has amassed an impressive portfolio of over 50 peer-reviewed publications, addressing both common and rare oncological conditions, contributing significantly to the evolving understanding of oncopathology. He is recognized for his comprehensive approach that merges histopathology, cytopathology, hematopathology, and molecular pathology. As a reviewer, invited speaker, and research presenter at both national and international platforms, he exemplifies the qualities of a dedicated and visionary medical researcher. His contributions to both clinical practice and research make him a pivotal figure in the Indian medical community and a strong candidate for national and international honors in the field of cancer pathology.

Professional Profile

Education

Dr. Chowdhury’s academic journey began with outstanding scholastic achievements, securing the 5th rank in his Higher Secondary School Examination from Cotton College, Guwahati, with a remarkable 83.6% score. He earned his MBBS from Assam Medical College under Dibrugarh University in 2004, ranking 2nd in his final examinations. His dedication to medical sciences continued with an MD in Pathology in 2011 from the same institution, where he again demonstrated academic excellence by clearing all examinations in his first attempt. Complementing his postgraduate training, Dr. Chowdhury was awarded the prestigious UICC/Dr. Praful Desai Fellowship in Oncopathology at Tata Memorial Centre, Mumbai, where he further honed his expertise in histopathology, cytopathology, and molecular diagnostics. Additionally, he underwent advanced training in molecular pathology at Tata Medical Centre, Kolkata, and Tata Memorial Centre, Parel, reinforcing his foundation in modern cancer diagnostics. His academic credentials are supported by multiple merit certificates from the Assam Higher Secondary Education Council, All Assam Students Union, and Assam Medical College, highlighting consistent academic distinction from secondary education through to his postgraduate years. This strong educational foundation has enabled Dr. Chowdhury to effectively lead both clinical and academic responsibilities in the field of oncopathology.

Professional Experience

Dr. Zachariah Chowdhury has accumulated rich and diverse professional experience across multiple prestigious institutions. He began his teaching career as a Senior Resident Doctor at the North Eastern Indira Gandhi Regional Institute of Health and Medical Sciences (NEIGRIHMS), Shillong, where he served for three years post-MD, laying a strong foundation in clinical pathology and academic instruction. Currently, he serves as Professor and Officer-in-Charge of the Department of OncoPathology at MPMMCC & HBCH in Varanasi, both units under the Tata Memorial Centre. In this leadership role, he oversees academic training and diagnostic services in a high-volume cancer care setting. Dr. Chowdhury’s responsibilities include teaching DM (OncoPathology), MD (Pathology), MBBS, nursing, and laboratory science students in both theory and laboratory environments. His clinical expertise encompasses a wide spectrum, including histopathology, cytopathology, hematopathology, molecular diagnostics, clinical pathology, renal pathology, immunopathology, and blood banking. Additionally, he plays an active role in quality assurance programs within the diagnostic laboratory. Beyond his hospital commitments, he contributes to academia as a peer reviewer for multiple reputed medical journals and participates in national and international conferences as a speaker, panelist, and faculty. This blend of academic, clinical, and leadership experience underscores his stature as a seasoned medical professional.

Research Interest

Dr. Chowdhury’s research interests center around oncopathology with a multidisciplinary focus that integrates histopathology, molecular pathology, cytopathology, and hematopathology. His scholarly work investigates a wide range of oncological conditions, including breast cancer, thyroid lesions, ovarian tumors, pediatric malignancies, head and neck cancers, and hematolymphoid neoplasms. A key area of his research explores the diagnostic challenges and spectrum of rare tumors such as salivary gland neoplasms, solitary fibrous tumors, and angiosarcomas, with a special emphasis on cytohistological correlations and immunomorphological profiling. Additionally, he has contributed to understanding emerging themes like artificial intelligence in histopathology and the role of molecular diagnostics in rare malignancies. His recent studies include real-world clinical data on metastatic cancers and chemotherapy outcomes, bridging clinical practice with diagnostic research. Dr. Chowdhury’s commitment to evidence-based pathology is evident in his methodical approach to publishing both retrospective reviews and case-based literature, offering valuable insights to the global oncopathology community. His collaborations with multidisciplinary teams from oncology, radiology, and surgery reflect his integrative research philosophy. By focusing on both common diagnostic patterns and rare, underreported entities, his work not only advances academic pathology but also significantly contributes to clinical decision-making and patient outcomes.

Research Skills

Dr. Zachariah Chowdhury brings to the research landscape a comprehensive skill set encompassing classical and modern pathology techniques. He is proficient in histological examination, cytopathological evaluations (including FNAC and core biopsies), hematopathology analyses, and cutting-edge molecular diagnostics. His training at leading cancer centers like Tata Memorial Centre and Tata Medical Centre has equipped him with practical expertise in PCR, FISH, and immunohistochemistry techniques—essential tools in the molecular characterization of tumors. He also has expertise in immunomorphology and has applied these skills across a broad range of clinical cases, from pediatric cancers to high-grade lymphomas and soft tissue tumors. Dr. Chowdhury is also skilled in academic writing and statistical analysis, as evidenced by his extensive publication record across peer-reviewed indexed journals. His systematic approach to clinical audits, retrospective analyses, and diagnostic algorithm development further highlight his research rigor. Additionally, he has contributed to AI applications in cancer diagnosis, showcasing adaptability to new technologies. His experience in organizing research presentations and mentoring junior faculty and students also reflects strong leadership and team management skills within research settings. Altogether, his multidimensional research skills strongly align with the goals of translational oncology and precision medicine.

Awards and Honors

Dr. Chowdhury’s illustrious career has been recognized with numerous awards and honors, validating his significant impact in the field of pathology. Among the most notable are the Bharat Gaurav Puraskar (2023) and the Jewel of India Award (2024), both conferred by the KTK Outstanding Achievers and Education Foundation, New Delhi, for his exemplary contributions to pathology and medical education. During his academic years, he received multiple certificates of merit for academic excellence, including top ranks in both secondary and medical school examinations. His postgraduate performance earned him a Certificate of Merit from Assam Medical College. As a faculty member and researcher, he has consistently excelled in academic events, winning the first prize in Oral Paper Presentation at the 5th International Pediatric Pathology Conference (2022) and the Poster Presentation at NEIGRIHMS Annual Research Day (2018). His early career awards also include the North Eastern Council (NEC) Scholarship for MBBS, which supported his foundational medical education. Beyond these, his recognition extends to being a respected reviewer for multiple journals, and his frequent roles as invited speaker and panelist at various conferences. These accolades reflect both peer and institutional acknowledgment of his enduring impact on medical research and education.

Conclusion

Dr. Zachariah Chowdhury exemplifies the ideals of a clinician-scientist dedicated to excellence in oncopathology. With a firm grounding in both classical pathology and modern diagnostic innovations, he bridges the gap between histological diagnosis and translational cancer research. His career reflects a rare combination of clinical acumen, academic mentorship, research productivity, and institutional leadership. Through his prolific authorship of over 50 peer-reviewed publications, he contributes actively to the global understanding of complex and rare oncological entities. His commitment to education is evident in his multi-level teaching engagements and ongoing mentorship of pathology trainees. Dr. Chowdhury’s recognition through multiple national honors and academic awards further substantiates his role as a leading figure in cancer pathology in India. While already operating at a high level of academic and clinical distinction, future initiatives such as enhanced international collaborations, grant-funded research, and patent development would elevate his profile even further. Overall, Dr. Chowdhury represents a distinguished and highly qualified candidate for any recognition aimed at honoring pathologists and researchers who make substantial contributions to medical science, and particularly, to the evolving discipline of oncopathology.

Publications Top Notes

1. The many faces of ovarian sex cord stromal tumors: a clinicopathological analysis at a tertiary cancer center in North India

  • Year: 2025

  • Authors: Chowdhury Z, Agrawal S, Gupta S, Rai S, Jethani R, Saha S, Ranjan R, Pal A

  • Journal: Surgical and Experimental Pathology

2. The Myriad Spectrum of Salivary Gland Lesions: Cytohistological Correlation on Fine Needle Aspiration Cytology, Core Needle Biopsy, and Resections in a 5-Year Single Institutional Experience of North India

  • Year: 2025

  • Authors: Chowdhury Z, Majumdar P, Narain S, Lamba K

  • Journal: Diagnostic Cytopathology

3. ALK-positive large B-cell lymphoma: A study of six cases from an oncopathology center in North India

  • Year: 2025

  • Authors: Verma A, Chowdhury Z, Singh A, Kant A, Yadav A, Patne SCU

  • Journal: Indian Journal of Pathology and Microbiology

4. Cyto-Histomorphological Analysis of Thyroid Lesions and Risk Assessment of Malignancy/Neoplasia: Insights from a North Indian Tertiary Oncology Center

  • Year: 2025

  • Authors: Haiyat S, Chowdhury Z, Rudra Pal P, Patne S, Dhal I, Paul P

  • Journal: Cureus

5. An Analysis of Pediatric Round Cell Tumors Highlighting the Spectrum of Differential Diagnosis – A Single Center Experience and Systematic Review of Literature

  • Year: 2025

  • Authors: Dhal I, Lali BS, Rai H, Chowdhury Z, Patne S, Tripathi P, Saha S

  • Journal: International Journal of Scientific Studies

6. Real-world data on trastuzumab emtansine (TDM1) efficacy and safety: Results of a single-centre retrospective study of HER2-positive metastatic breast cancer patients

  • Year: 2025

  • Authors: Gupta A, Sansar B, Mishra BK, Khan A, Singh A, Upadhyay A, Chowdhury Z, Patne S, Tripathi M, et al.

  • Journal: Scientific Reports

7. Triple Oral Metronomic Chemotherapy Versus Chemotherapy of Physician Discretion After Failure of Platinum-Based Therapy in Advanced Head and Neck Cancer: A Phase III Randomized Study (METRO-CHASE Study)

  • Year: 2025

  • Authors: Kapoor A, Gupta A, Sansar B, Mishra BK, Gupta P, Singh A, Upadhyay A, Kashyap L, Pal A, Kumar A, Nanda SS, Mukherji A, Kapoor AR, Pradhan S, Mishra A, Chowdhury Z, Patne S, Dhal I, Singh N, et al.

  • Journal: JCO Global Oncology

8. Exploring Solitary Fibrous Tumors at a Tertiary Cancer Center: Clinicopathological and Immunomorphologic Profile

  • Year: 2024

  • Authors: Chowdhury Z, Mishrikotkar S, Nehra P, Patne S, Tripathi M

  • Journal: Cureus

9. A Review of the Applications of Artificial Intelligence in Histopathology

  • Year: 2024

  • Authors: Kandarpa S, Chowdhury Z, Pal PR, Rajput K, Saraf SA

  • Journal: Journal of Cancer Research Reviews & Reports

10. Outcomes of De Novo Oligometastatic Breast Cancer Treated With Surgery of Primary and Metastasis Directed Radiotherapy

  • Year: 2024

  • Authors: Pujari L, Suresh A, Chowdhury Z, Pradhan S, Tripathi M, Gupta A, Singh P, Giridhar P, Kapoor AR, Shinghal A, Sansar B, Mv M

  • Journal: American Journal of Clinical Oncology

 

Nobuhiro Takahashi | Medicine and Dentistry | Best Researcher Award

Posted on by Shen Awards

Dr. Nobuhiro Takahashi | Medicine and Dentistry | Best Researcher Award

Dermatologist from Tokai University School of Medicine, Japan

Dr. Nobuhiro Takahashi is a dedicated clinical professional specializing in dermatology, with a primary focus on inflammatory skin diseases. Currently serving as a Clinical Assistant in the Department of Dermatology at Tokai University Hospital, Kanagawa, Japan, Dr. Takahashi actively participates in both clinical practice and academic training. He has demonstrated a strong commitment to advancing patient care in outpatient dermatology. His work reflects a growing interest in combining clinical insights with research opportunities. With a solid foundation in medical education and practical experience, Dr. Takahashi shows promise for contributing significantly to dermatological research in the future.

Professional Profile

Education

Dr. Nobuhiro Takahashi completed his medical degree at Tokai University School of Medicine, Japan, graduating in March 2020. His academic training provided him with a comprehensive understanding of medical sciences, with a particular interest in dermatology developing during his studies. The rigorous curriculum at Tokai University laid the groundwork for his clinical reasoning, diagnostic skills, and patient management techniques. His education emphasized both theoretical knowledge and practical application, preparing him effectively for postgraduate clinical training and his current clinical role. Dr. Takahashi’s education continues to support his professional development and potential future contributions to clinical research.

Professional Experience

Dr. Takahashi began his professional journey as a Clinical Resident at Tokai University Hospital, where he completed a two-year postgraduate clinical training program from April 2020 to March 2022. This experience allowed him to build strong diagnostic and treatment skills across multiple medical disciplines. Since April 2022, he has been serving as a Clinical Assistant in the Department of Dermatology at Tokai University. In this role, he focuses on outpatient clinical dermatology and academic training, working closely with specialists to manage a variety of dermatological conditions. His current responsibilities allow him to blend clinical service with ongoing professional growth.

Research Interest

Dr. Takahashi’s primary research interests center around dermatology, particularly the study and management of inflammatory skin diseases. He is focused on improving clinical outcomes and advancing therapeutic strategies for these complex skin conditions. His exposure to diverse patient cases in an outpatient setting provides valuable clinical observations that can guide his research direction. While his current profile does not extensively detail research projects or publications, his interest in bridging clinical practice with academic research is evident. Dr. Takahashi is well-positioned to contribute to future dermatological studies that address common and challenging skin disorders.

Research Skills

Dr. Takahashi has developed a strong set of clinical and observational skills through his extensive outpatient dermatology practice. His ability to diagnose, monitor, and manage various skin conditions equips him with firsthand clinical insights essential for relevant and impactful research. Although specific laboratory or advanced research techniques are not detailed in his profile, his clinical experience supports potential development in clinical research methodologies, case study analysis, and patient-centered research. His ongoing academic training is expected to enhance his research capabilities further, enabling him to contribute to clinical trials and evidence-based dermatology studies.

Award and Honors

At this stage of his career, Dr. Takahashi has not yet received formal awards or honors in the field of dermatology or medical research. His professional achievements thus far reflect his dedication to clinical practice and academic growth. As he continues to develop his research portfolio and engage in scholarly activities, there is significant potential for him to earn recognition in the future. Participation in conferences, collaborative research, and contributions to peer-reviewed publications will likely pave the way for future awards and academic honors that acknowledge his efforts in advancing dermatological science.

Conclusion

In conclusion, Dr. Nobuhiro Takahashi is an emerging clinical dermatologist with a promising future in research. His solid educational background, hands-on clinical experience, and keen interest in inflammatory skin diseases demonstrate his dedication to the field. Although he currently has limited research output and formal recognitions, his trajectory indicates potential for future contributions to dermatological science. With continued clinical engagement, research involvement, and academic participation, Dr. Takahashi can develop into a respected researcher who significantly impacts both patient care and dermatological research. His career is well-positioned for continued growth and achievement.

Publication Top Note

  1. Title: A Case of Primary Cutaneous CD8+ Aggressive Epidermotropic Cytotoxic T-Cell Lymphoma
  • Journal: JEADV Clinical Practice
  • Year: 2025

 

Catarina Eloy | Health Professions | Women Researcher Award

Posted on by Shen Awards

Prof. Catarina Eloy | Health Professions | Women Researcher Award

IPATIMUP, Portugal

Dr. Catarina Eloy is a distinguished pathologist and researcher specializing in digital pathology and oncologic diagnostics. She has significantly contributed to the integration of artificial intelligence (AI) in pathology, enhancing diagnostic accuracy and efficiency. As a key figure in the HEROHE Challenge, Dr. Eloy collaborated with international experts to develop AI models for predicting HER2 status in breast cancer using hematoxylin–eosin-stained whole-slide images. Her work emphasizes the importance of digital tools in modern pathology, aiming to bridge the gap between traditional histopathology and emerging computational methods. Dr. Eloy’s research has been pivotal in advancing the field, particularly in the context of the COVID-19 pandemic, where digital pathology played a crucial role in maintaining diagnostic services. Her contributions extend beyond research, as she actively participates in international collaborations and initiatives to promote the adoption of digital pathology worldwide. Dr. Eloy’s dedication to innovation and excellence has established her as a leading authority in the field, influencing both clinical practice and research methodologies in pathology.

Professional Profile

Education

Dr. Catarina Eloy’s educational background is rooted in medicine and pathology, providing a strong foundation for her career in digital pathology and oncologic diagnostics. She obtained her medical degree from a reputable institution, followed by specialized training in pathology. Her academic pursuits included advanced studies in digital pathology, where she focused on integrating computational tools with traditional histopathological techniques. Dr. Eloy’s commitment to education is evident through her involvement in various training programs and workshops aimed at disseminating knowledge in digital pathology. She has also contributed to academic literature, authoring several publications that serve as educational resources for both students and professionals in the field. Her educational journey reflects a continuous pursuit of knowledge and a dedication to advancing the field of pathology through both learning and teaching.

Professional Experience

Dr. Catarina Eloy has amassed extensive professional experience in pathology, with a particular focus on digital pathology and oncologic diagnostics. She has held key positions in various institutions, where she has been instrumental in implementing digital pathology workflows and integrating AI tools into diagnostic processes. Her professional journey includes collaborative projects like the HEROHE Challenge, where she worked alongside international experts to develop AI models for breast cancer diagnostics. Dr. Eloy has also contributed to global initiatives aimed at promoting digital pathology, especially during the COVID-19 pandemic, highlighting the importance of digital tools in maintaining diagnostic services. Her leadership and expertise have significantly influenced the adoption of digital pathology practices, enhancing diagnostic accuracy and efficiency across various healthcare settings.

Research Interests

Dr. Catarina Eloy’s research interests are centered around the integration of digital tools in pathology, with a particular emphasis on artificial intelligence and its applications in oncologic diagnostics. She is deeply involved in exploring how AI can enhance the accuracy and efficiency of pathological diagnoses, especially in breast cancer. Her work in the HEROHE Challenge exemplifies her commitment to developing AI models that can predict HER2 status from histopathological images, thereby contributing to personalized medicine. Additionally, Dr. Eloy is interested in the broader implications of digital pathology, including its role in global health and its potential to revolutionize diagnostic practices. Her research aims to bridge the gap between traditional pathology and emerging digital technologies, fostering innovation in diagnostic methodologies.

Research Skills

Dr. Catarina Eloy possesses a robust set of research skills that underpin her contributions to digital pathology and oncologic diagnostics. Her expertise includes proficiency in histopathological analysis, digital imaging, and the application of AI algorithms in diagnostic processes. She is adept at designing and conducting research studies that explore the integration of digital tools in pathology, as evidenced by her involvement in the HEROHE Challenge. Dr. Eloy is also skilled in collaborative research, working with multidisciplinary teams to advance the field of digital pathology. Her analytical capabilities and methodological rigor have been instrumental in producing high-impact research that informs both clinical practice and future studies.

Awards and Honors

Dr. Catarina Eloy’s contributions to pathology have been recognized through various awards and honors. Her work in digital pathology and AI integration has garnered international attention, leading to accolades that highlight her influence in the field. While specific awards are not detailed in the available sources, her leadership roles in significant projects like the HEROHE Challenge and her involvement in global initiatives during the COVID-19 pandemic underscore her esteemed position in the pathology community. These recognitions reflect her dedication to advancing pathology through innovation and collaboration.

Conclusion

Dr. Catarina Eloy’s career embodies a commitment to innovation, collaboration, and excellence in pathology. Her pioneering work in digital pathology and the integration of AI into diagnostic processes has significantly advanced the field, offering new avenues for accurate and efficient patient care. Through initiatives like the HEROHE Challenge, she has demonstrated the potential of interdisciplinary collaboration in developing cutting-edge diagnostic tools. Dr. Eloy’s contributions during the COVID-19 pandemic further highlight the critical role of digital pathology in maintaining healthcare services amidst global challenges. Her dedication to research, education, and professional development continues to inspire advancements in pathology, solidifying her status as a leading figure in the field.

Publications Top Notes

  • Title: Classification of breast cancer histology images using convolutional neural networks
    Authors: T. Araújo, G. Aresta, E. Castro, J. Rouco, P. Aguiar, C. Eloy, A. Polónia, …
    Journal: PLoS ONE, 12(6): e0177544
    Year: 2017
    Citations: 1162

  • Title: Bach: Grand challenge on breast cancer histology images
    Authors: G. Aresta, T. Araújo, S. Kwok, S. S. Chennamsetty, M. Safwan, V. Alex, …
    Journal: Medical Image Analysis, 56: 122–139
    Year: 2019
    Citations: 742

  • Title: TERT promoter mutations are a major indicator of poor outcome in differentiated thyroid carcinomas
    Authors: M. Melo, A. G. da Rocha, J. Vinagre, R. Batista, J. Peixoto, C. Tavares, …
    Journal: The Journal of Clinical Endocrinology & Metabolism, 99(5): E754–E765
    Year: 2014
    Citations: 641

  • Title: Follicular thyroid carcinoma
    Authors: M. Sobrinho-Simões, C. Eloy, J. Magalhães, C. Lobo, T. Amaro
    Journal: Modern Pathology, 24: S10–S18
    Year: 2011
    Citations: 223

  • Title: Genetic alterations in poorly differentiated and undifferentiated thyroid carcinomas
    Authors: P. Soares, J. Lima, A. Preto, P. Castro, J. Vinagre, R. Celestino, J. P. Couto, …
    Journal: Current Genomics, 12(8): 609–617
    Year: 2011
    Citations: 127

  • Title: Best practice recommendations for the implementation of a digital pathology workflow in the anatomic pathology laboratory by the European Society of Digital and Integrative Pathology
    Authors: F. Fraggetta, V. L’imperio, D. Ameisen, R. Carvalho, S. Leh, T. R. Kiehl, …
    Journal: Diagnostics, 11(11): 2167
    Year: 2021
    Citations: 92

  • Title: NIS expression in thyroid tumors, relation with prognosis clinicopathological and molecular features
    Authors: C. Tavares, M. J. Coelho, C. Eloy, M. Melo, A. G. da Rocha, A. Pestana, …
    Journal: Endocrine Connections, 7(1): 78–90
    Year: 2018
    Citations: 85

  • Title: Automatic classification of tissue malignancy for breast carcinoma diagnosis
    Authors: I. Fondón, A. Sarmiento, A. I. García, M. Silvestre, C. Eloy, A. Polónia, P. Aguiar
    Journal: Computers in Biology and Medicine, 96: 41–51
    Year: 2018
    Citations: 83

  • Title: Computational pathology in 2030: a Delphi study forecasting the role of AI in pathology within the next decade
    Authors: M. A. Berbís, D. S. McClintock, A. Bychkov, J. Van der Laak, L. Pantanowitz, …
    Journal: EBioMedicine, 88
    Year: 2023
    Citations: 78

  • Title: Cribriform-morular variant of thyroid carcinoma: a neoplasm with distinctive phenotype associated with the activation of the WNT/β-catenin pathway
    Authors: J. M. Cameselle-Teijeiro, D. Peteiro-González, J. Caneiro-Gómez, …
    Journal: Modern Pathology, 31(8): 1168–1179
    Year: 2018
    Citations: 72

Huan-You Wang | Health Professions | Best Academic Researcher Award

Posted on by Shen Awards

Prof. Huan-You Wang | Health Professions | Best Academic Researcher Award

Professor of Pathology, Director of Hematopathology Fellowship, Associate Vice Chair for Education and Academic Affairs, University of California San Diego, United States

Dr. Huan-You Wang is a distinguished Clinical Professor of Pathology at the University of California, San Diego (UCSD), where he also serves as the Medical Director of the Clinical Hematology Laboratory. With an extensive career in academic medicine and clinical diagnostics, Dr. Wang has made significant contributions to the field of hematopathology. His research primarily focuses on hematologic malignancies, including leukemia, lymphoma, and myelodysplastic syndromes. Dr. Wang’s expertise encompasses molecular diagnostics, flow cytometry, and the integration of advanced genomic techniques into clinical practice. He has authored over 160 peer-reviewed publications, reflecting his commitment to advancing medical knowledge and improving patient care. Beyond his clinical and research endeavors, Dr. Wang has played a pivotal role in medical education, mentoring numerous trainees and contributing to the development of pathology fellowship programs at UCSD. His leadership extends to professional organizations, having served as the President of the Chinese American Pathologists Association (CAPA) from 2019 to 2020. Dr. Wang’s dedication to excellence in pathology has earned him recognition as a leader in his field, influencing both national and international practices in hematopathology.

Professional Profile

Education

Dr. Wang’s academic journey began at Tongji Medical University in Wuhan, China, where he served as a Graduate Research Associate in the Department of Pathology from 1987 to 1990. He then held an instructor position at Peking University Health Sciences Center in Beijing from 1990 to 1992. Pursuing advanced education, Dr. Wang completed his MD and PhD at the University of California, San Diego, specializing in Molecular Pathology and Cellular and Molecular Medicine between 1994 and 2000. This rigorous training provided him with a robust foundation in both clinical medicine and biomedical research, equipping him with the skills necessary to excel in the complex field of hematopathology. His educational background reflects a blend of international experience and interdisciplinary expertise, contributing to his comprehensive approach to pathology and research.

Professional Experience

Dr. Wang’s professional career is marked by a series of esteemed positions in academic and clinical settings. From 2005 to 2009, he served as an Assistant Professor of Pathology at the University of Texas Southwestern Medical Center in Richardson, Texas. In 2009, he joined the University of California, San Diego, where he currently holds the position of Clinical Professor of Pathology. At UCSD, Dr. Wang also serves as the Medical Director of the Clinical Hematology Laboratory, overseeing diagnostic services and contributing to the advancement of laboratory practices. His roles have encompassed clinical diagnostics, research, and education, reflecting a commitment to integrating scientific discovery with patient care. Dr. Wang’s leadership in these capacities has significantly influenced the development of pathology services and the training of future medical professionals.

Research Interests

Dr. Wang’s research interests are centered on the pathogenesis and diagnosis of hematologic malignancies. He has extensively studied various forms of leukemia and lymphoma, focusing on the molecular and cellular mechanisms underlying these diseases. His work often involves the application of advanced techniques such as flow cytometry, molecular diagnostics, and genomic analysis to improve diagnostic accuracy and patient outcomes. Dr. Wang is particularly interested in the identification of novel biomarkers and therapeutic targets, aiming to enhance personalized medicine approaches in hematopathology. His research contributes to a deeper understanding of disease processes and the development of innovative diagnostic and treatment strategies.

Research Skills

Dr. Wang possesses a comprehensive skill set that encompasses various methodologies essential to modern pathology research. His expertise includes flow cytometry, which he utilizes for immunophenotypic analysis of hematologic malignancies. He is proficient in molecular diagnostic techniques, such as polymerase chain reaction (PCR) and next-generation sequencing (NGS), enabling the detection of genetic mutations and chromosomal abnormalities. Dr. Wang also employs immunohistochemistry for the characterization of tissue samples, contributing to accurate disease classification. His skills extend to the interpretation of complex data sets, integrating clinical findings with laboratory results to inform diagnostic and therapeutic decisions. This multifaceted expertise allows Dr. Wang to conduct comprehensive research that bridges laboratory science and clinical application.

Awards and Honors

Throughout his career, Dr. Wang has received numerous accolades recognizing his contributions to pathology and medical research. Notably, he served as the President of the Chinese American Pathologists Association (CAPA) from 2019 to 2020, reflecting his leadership and commitment to the professional community. His extensive publication record, comprising over 160 peer-reviewed articles, underscores his influence in the field and dedication to advancing scientific knowledge. Dr. Wang’s work has garnered citations and recognition from peers, highlighting the impact of his research on the understanding and management of hematologic diseases. These honors attest to his role as a leading figure in pathology, contributing to both academic excellence and clinical innovation.

Conclusion

Dr. Huan-You Wang’s career exemplifies a harmonious blend of clinical practice, research, and education in the field of pathology. His dedication to understanding hematologic malignancies has led to significant advancements in diagnostic methodologies and patient care. Through his leadership roles, including his tenure as President of CAPA, Dr. Wang has influenced the direction of pathology practice and fostered professional development within the community. His commitment to mentorship and education ensures the cultivation of future experts in the field. Dr. Wang’s contributions continue to shape the landscape of hematopathology, reflecting a career devoted to scientific inquiry, clinical excellence, and the betterment of patient outcomes.

Publications Top Notes

  1. Title: Isolated Monoclonal T-Cell Receptor Gene Rearrangement in a Lung Adenocarcinoma Harboring MET Exon 14 Skipping: Diagnostic Pitfall
    Authors: Shi, Wangpan Jackson; Nguyen, Joshua J.; Song, Wei W.; Fadare, Oluwole O.; Lei, Li L.
    Journal: International Journal of Surgical Pathology
    Year: 2025

  2. Title: Intratumoral Injection of Cytotoxic Drugs Plus Hapten Elicits Significant Immune Responses in Sentinel Lymph Nodes: Implications for Cancer Immunotherapy
    Authors: Yu, Baofa B.; Zhang, Jian J.; Han, Yan Y.; Zhou, Shengjun S.; Wang, Huanyou H.
    Journal: Pancreas
    Year: 2025

  3. Title: Erythroblastic Sarcoma in Adults and Children: Different Pathways to the Same Destination
    Authors: Fitzpatrick, Megan J.; Yuan, Ji J.; Capa, Ioana I.; Medeiros, Leonard Jeffrey L.; Pan, Zenggang Z.
    Journal: Modern Pathology
    Year: 2025

  4. Title: Mutation in Bruton Tyrosine Kinase (BTK) A428D Confers Resistance to BTK-Degrader Therapy in Chronic Lymphocytic Leukemia
    Authors: Wong, Richard L.; Choi, Michael Youngjun M.Y.; Wang, Huanyou H.; Kipps, Thomas J.
    Type: Letter
    Year: 2025
    Citations: 9

  5. Title: A CD10-Negative Adult B-Lymphoblastic Leukemia with Amplification of KMT2A Without Rearrangement: A Case Report and Review of the English Literature
    Authors: Wang, Huanyou H.; Louis, Hailee M.St H.M.S.; Costello, Caitlin L.C.L.; Murray, Sarah Shaw S.S.; Dell’Aquila, Marie L.M.L.
    Year: 2025

  6. Title: Indolent T-Cell/Natural Killer-Cell Lymphomas/Lymphoproliferative Disorders of the Gastrointestinal Tract—What Have We Learned in the Last Decade?
    Authors: Wang, Xingen X.; Yin, Weihua W.; Wang, Huanyou H.
    Type: Review
    Year: 2025

  7. Title: Nuclear Morphology is Shaped by Loop-Extrusion Programs
    Authors: Patta, Indumathi I.; Zand, Maryam M.; Lee, Lindsay L.; Hu, Ming M.; Murre, Cornelis C.
    Journal: Nature
    Year: 2024
    Citations: 3

  8. Title: IDH2-Mutated Near ETP-ALL with Aggressive Leukemia Cutis and Brisk Response to Venetoclax and Decitabine
    Authors: Vaidya, Poorva P.; Wang, Huanyou H.; Don, Michelle D.M.D.; Hinds, Brian R.B.R.; Mangan, James K.J.K.
    Journal: Leukemia Research Reports
    Year: 2024
    Citations: 1

  9. Title: Myeloid Lineage Switch Following CD7-Targeted Chimeric Antigen Receptor T-Cell Therapy in Relapsed/Refractory T-Cell Acute Lymphoblastic Leukemia
    Authors: Aldoss, Ibrahim T.I.T.; Tizro, Parastou P.; Bedi, Davsheen D.; Wang, Huanyou H.; Afkhami, Michelle M.
    Journal: Haematologica
    Year: 2023
    Citations: 3

  10. Title: A Cell-Level Discriminative Neural Network Model for Diagnosis of Blood Cancers
    Authors: Robles, Edgar E.E.; Jin, Ye Y.; Smyth, Padhraic P.; Oak, Jean S.J.S.; Qian, Yu Y.
    Journal: Bioinformatics
    Year: 2023
    Citations: 4

Lakovos Nomikos | Health Professions | Outstanding Scientist Award

Posted on by Shen Awards

Prof. Dr. Lakovos Nomikos | Health Professions | Outstanding Scientist Award

MD, PhD, FACS from European University Cyprus Nicosia Cyprus, Rea Maternity Hospital Athens Greece, Greece

Dr. Iakovos N. Nomikos, MD, PhD, FACS, is a distinguished academic surgeon with over four decades of experience in clinical practice, research, and medical education. Born on October 1, 1951, in Greece, Dr. Nomikos has dedicated his career to advancing surgical science, with particular contributions in the fields of transplantation biology, metabolic support for critical illness, and oncologic surgery. He has held significant roles in both academic and hospital settings, including Assistant Professor and Chairman of Surgery at major institutions. His extensive training includes fellowships in the United States and the United Kingdom, reflecting a broad international perspective and collaboration. Dr. Nomikos is a Fellow of the American College of Surgeons and a respected member of multiple medical societies. His work spans a wide range of clinical and research domains, and he is widely recognized for his mentorship, leadership, and commitment to the integration of scientific innovation into surgical practice. His contributions have been presented in international conferences, lectures, and numerous publications in both Greek and English literature. Dr. Nomikos continues to serve as an adjunct professor, influencing the next generation of medical professionals while remaining actively engaged in clinical and academic research.

Professional Profile

Education

Dr. Iakovos N. Nomikos pursued his early education at the “Gymnasium” High School in Syros, Cyclades, Greece, from 1963 to 1969, graduating with excellence. He then entered the Medical School of Athens University, where he studied from 1969 to 1975. His academic record was exemplary, achieving an “excellency” degree. The medical program at Athens University included an integrated internship in the final year, consisting of clinical rotations in internal medicine, surgery, pediatrics, and obstetrics-gynecology. This foundational training provided him with a solid grounding in multiple medical disciplines. Following his medical degree, Dr. Nomikos completed a residency in General Surgery at “Evagelismos” Medical Center in Athens from 1975 to 1980. His postgraduate education continued through prestigious fellowships in surgical nutrition, transplantation biology, critical care, and hepatobiliary surgery at world-renowned institutions such as the University of Colorado Health Sciences Center, New York Medical College, and The Queen Elizabeth Hospital in Birmingham, England. These advanced studies and international experiences significantly enriched his clinical knowledge and research capabilities, positioning him as a leader in surgical education and innovation. His diverse academic training has underpinned a career defined by scientific inquiry, clinical excellence, and global collaboration.

Professional Experience

Dr. Nomikos’s professional career spans several decades, marked by progressive responsibility and distinction in surgical practice and academic leadership. His early career began with positions as an attending surgeon at Evangelismos Medical Center and Larissa General Hospital in Greece. From 1987 to 2004, he served in the Department of Surgery at Tzanion General Hospital, Piraeus, progressing from attending surgeon to associate director. In 2004, he was appointed Chairman of Surgery at Metaxa Cancer Memorial Hospital, where he served until 2018, overseeing clinical operations, research, and resident education. Since 2019, he has continued practicing surgery in the private sector at Rea Maternity Hospital and Metropolitan General Hospital in Athens. In parallel with his clinical duties, Dr. Nomikos has held academic positions, including Lecturer and Assistant Professor of Surgery at Athens University and currently serves as Adjunct Professor of Surgery at the European University of Cyprus. His teaching responsibilities span both the School of Medicine and the Department of Life Sciences. Throughout his career, he has played a vital role in shaping surgical education programs and mentoring young professionals. His leadership has consistently integrated evidence-based practice with clinical innovation, reinforcing his reputation as a pillar of surgical excellence in Greece and beyond.

Research Interests

Dr. Iakovos N. Nomikos has cultivated a robust and diverse research portfolio throughout his career, combining basic science with applied clinical studies. His early research focused on transplantation biology, with particular emphasis on pancreatic islet transplantation for insulin-dependent diabetes mellitus (IDDM), examining graft destruction mechanisms. He has also extensively studied ischemia-reperfusion injury, a critical area in transplantation and trauma surgery. Another major area of interest includes the cellular biology of peritonitis, where he has investigated immune response and inflammation in abdominal infections. In applied research, Dr. Nomikos has addressed practical clinical challenges such as peritoneal infections, neo-adjuvant chemotherapy for solid tumors, metabolic responses in critically ill surgical patients, and functional staging of acute surgical illness. His interest in surgical metabolism and nutrition has informed clinical protocols that improve recovery and outcomes in post-operative and intensive care settings. These research interests not only highlight his interdisciplinary approach but also reflect a commitment to enhancing surgical care through scientific advancement. Dr. Nomikos’s work stands at the intersection of innovation and clinical relevance, aiming to translate laboratory discoveries into improved patient outcomes. His efforts have contributed significantly to the fields of surgical oncology, critical care, and transplant medicine.

Research Skills

Dr. Nomikos brings an exceptional set of research skills developed through decades of clinical practice, international training, and academic scholarship. His expertise spans both bench-side experimentation and bedside clinical research. In basic science, he is skilled in experimental models of islet transplantation, immunological assays, and the study of cellular mechanisms involved in ischemia-reperfusion injury and peritonitis. His training in the United States and the UK equipped him with advanced competencies in surgical research methodologies, including critical care and transplant-related studies. In clinical research, he excels in protocol development, data analysis, clinical trial execution, and outcome evaluation, particularly in surgical oncology and critical care settings. He has led and participated in projects focusing on chemotherapy protocols, surgical metabolic support, and the functional assessment of acute surgical conditions. Dr. Nomikos is also adept at medical writing, scientific presentation, and research mentoring, contributing significantly to academic publications, oral communications, and educational leadership. His ability to bridge theoretical science with surgical practice exemplifies translational research at its best. These multifaceted skills have enabled him to drive innovations in patient care, guide clinical decision-making, and mentor a generation of surgeon-scientists within Greece and internationally.

Awards and Honors

Dr. Iakovos N. Nomikos has received numerous honors and awards in recognition of his exceptional contributions to surgery, research, and education. He is a Fellow of the American College of Surgeons (FACS), a prestigious international credential that signifies excellence in surgical practice and ethics. His career achievements have been acknowledged through several institutional, national, and international recognitions, including leadership positions in major hospitals and academic programs. He has been honored for his work in surgical oncology, critical care, and transplantation science. Dr. Nomikos’s scholarly efforts have been consistently featured in leading international congresses, where he has delivered invited lectures, chaired roundtable discussions, and presented scientific exhibits. His teaching accomplishments have also been recognized by academic institutions where he has played a pivotal role in curriculum development and resident training. Moreover, his influence extends through professional societies, where he holds memberships that reflect both his scientific stature and dedication to interdisciplinary collaboration. These accolades collectively underscore a career marked by lifelong service to advancing surgical science and mentoring future generations of clinicians. His awards affirm his lasting impact on both the academic and medical communities, validating his status as a respected leader in the global surgical field.

Conclusion

Dr. Iakovos N. Nomikos exemplifies the ideal candidate for recognition through a Research for Outstanding Scientist Award. His career is defined by a seamless integration of academic rigor, clinical excellence, and translational research. From pioneering studies in transplantation biology to practical innovations in critical care and oncologic surgery, he has consistently addressed key challenges in surgical practice through scientific inquiry. His mentorship, leadership, and continued contributions as an adjunct professor demonstrate ongoing relevance and impact. With a history of productive research collaborations, international training, and a strong publication and presentation record, Dr. Nomikos has significantly advanced both theoretical and applied surgical knowledge. Although further visibility through recent high-impact publications or patent disclosures could strengthen his profile, the depth, breadth, and longevity of his contributions are clear. He has made lasting advancements in patient care, surgical methodology, and medical education. In conclusion, Dr. Nomikos’s distinguished achievements over several decades merit recognition not only as a leading figure in his field but also as a scientist whose work has tangibly improved lives and enriched the broader medical community. His career is a model of what sustained excellence and dedication in clinical research can accomplish.

Publications Top Notes

  • Combined treatment with nicotinamide and desferrioxamine prevents islet allograft destruction in NOD mice
    Authors: IN Nomikos, SJ Prowse, P Carotenuto, KJ Lafferty
    Journal: Diabetes, 35(11), 1302–1304
    Citations: 159
    Year: 1986

  • Prevention of postischaemic lipid peroxidation and liver cell injury by iron chelation
    Authors: R Omar, I Nomikos, G Piccorelli, J Savino, N Agarwal
    Journal: Gut, 30(4), 510–514
    Citations: 139
    Year: 1989

  • Involvement of O2 radicals in ‘autoimmune’ diabetes
    Authors: IN Nomikos, Y Wang, KJ Lafferty
    Journal: Immunology and Cell Biology, 67(1), 85–87
    Citations: 97
    Year: 1989

  • Washing with or without chloramphenicol in the treatment of peritonitis: a prospective, clinical trial
    Authors: IN Nomikos, K Katsouyanni, AN Papaioannou
    Journal: Surgery, 99(1), 20–25
    Citations: 64
    Year: 1986

  • Effect of cyclosporine on immunologically mediated diabetes in nonobese diabetic mice
    Authors: Y Wang, M McDuffie, IN Nomikos, L Hao, KJ Lafferty
    Journal: Transplantation, 46(2), 101S–106S
    Citations: 49
    Year: 1988

  • Current surgical aspects of palliative treatment for unresectable pancreatic cancer
    Authors: K Karapanos, IN Nomikos
    Journal: Cancers, 3(1), 636–651
    Citations: 28
    Year: 2011

  • Protective and damaging aspects of healing: A review
    Authors: IN Nomikos, C Malizos, NC Vamvakopoulos
    Journal: Wounds: A Compendium of Clinical Research and Practice, 18(7), 177–185
    Citations: 28
    Year: 2006

  • Practical approaches to effective management of intestinal radiation injury: benefit of resectional surgery
    Authors: N Perrakis, E Athanassiou, D Vamvakopoulou, M Kyriazi, H Kappos, …
    Journal: World Journal of Gastroenterology, 17(35), 4013
    Citations: 27
    Year: 2011

  • Carcinoma of the inguinal region arising from endometriosis of the round ligament. Report of a case
    Authors: J Elemenoglou, A Skopelitou, I Nomikos
    Journal: European Journal of Gynaecological Oncology, 14(1), 28–32
    Citations: 27
    Year: 1993

  • Tamoxifen-induced endometrial polyp. A case report and review of the literature
    Authors: IN Nomikos, J Elemenoglou, J Papatheophanis
    Journal: European Journal of Gynaecological Oncology, 392, 2936
    Citations: 23
    Year: 1998

Vanina Taliercio | Health Professions | Best Researcher Award

Posted on by Shen Awards

Assist. Prof. Dr. Vanina Taliercio | Health Professions | Best Researcher Award

Faculty, MD from University of Utah, United States

Dr. Vanina L. Taliercio is a physician-scientist whose career spans clinical practice, research, and academic leadership. Currently an Assistant Professor at the University of Utah, she brings extensive expertise in pediatrics, dermatology, genetics, and biomedical informatics. Her work integrates patient care with research, particularly focusing on genetic conditions, neurofibromatosis (NF), and tuberous sclerosis complex (TSC). Dr. Taliercio holds leadership roles as Co-director of both the NF and TSC clinics and serves as Associate Program Director for medical genetics and pediatrics/genetics programs. Her background includes significant contributions to national health initiatives, such as improving medication distribution systems for Hansen’s Disease in Argentina. In research, she has published several papers and presented at international conferences, particularly in dermatology and health informatics. Dr. Taliercio’s multidisciplinary approach, combining clinical insight with data-driven research, makes her a dynamic and impactful contributor to academic medicine. She is committed to advancing patient care, improving health outcomes, and mentoring the next generation of medical professionals.

Professional Profile

Education

Dr. Vanina Taliercio earned her Doctor of Medicine (MD) degree from Universidad del Salvador, Argentina, in 2002. To deepen her research expertise, she pursued a Master of Science (MS) in Biomedical Informatics at Oregon Health & Science University in 2012. Her postgraduate medical training is extensive and diverse. She completed a pediatrics residency at Pedro de Elizalde Hospital in Buenos Aires from 2003 to 2007, followed by a pediatric dermatology fellowship at Ramos Mejía Hospital from 2012 to 2015. After relocating to the United States, she undertook an ACGME residency in pediatrics at the University of Utah from 2020 to 2021, and most recently completed a medical genetics fellowship at the University of Utah between 2021 and 2023. This broad educational journey has equipped her with a unique combination of clinical and research expertise across multiple disciplines, positioning her well for leadership roles in academic medicine.

Professional Experience

Dr. Taliercio’s professional career spans several important roles in both Argentina and the United States. She began as a pediatrician at Hospital Italiano de Buenos Aires and OSDE, providing care to infants and children. She then worked as a clinical data research analyst, focusing on electronic health records, data reconciliation, and healthcare quality indicators, which led to key publications. At the national level, she contributed to Argentina’s Leprosy National Program, overseeing WHO medication distribution, developing national disease statistics, and creating educational materials to reduce stigma. Since moving to the United States, Dr. Taliercio has served as an Assistant Professor at the University of Utah, providing outpatient and inpatient care for patients with genetic and metabolic conditions. In addition, she co-directs two specialized clinics and supports the development of medical education programs as an Associate Program Director. Her career reflects a commitment to integrating clinical service, research, and academic leadership to improve patient care and healthcare systems.

Research Interests

Dr. Taliercio’s research interests span dermatology, genetics, pediatrics, and biomedical informatics. Her work has focused on psoriasis, alopecia, neurocutaneous disorders such as neurofibromatosis and tuberous sclerosis complex, and patient-reported outcomes. She is also interested in leveraging electronic health records and healthcare information systems to improve clinical decision-making and healthcare quality. Earlier in her career, she contributed to the development of mortality registries and national health databases, demonstrating a strong interest in population-level health outcomes and system-wide improvements. Her interdisciplinary approach combines clinical insights with data analysis, aiming to translate research findings into practical interventions that enhance patient care. She is particularly interested in collaborative, cross-disciplinary projects that bridge clinical practice with informatics tools and public health strategies.

Research Skills

Dr. Taliercio brings a broad set of research skills honed through years of clinical and academic work. She has expertise in clinical research design, data extraction and analysis from electronic health records, and the development of clinical research informatics tools. She has authored and co-authored several peer-reviewed publications and presented her work at national and international conferences. Dr. Taliercio has experience in conducting patient-reported outcomes research, implementing quality indicators in healthcare systems, and contributing to the development of national health guidelines. She also has teaching experience, having helped develop courses in clinical research and epidemiology. Her multidisciplinary training has given her strong analytical abilities, a deep understanding of clinical workflows, and the ability to bridge gaps between clinical practice and research. She is skilled at working collaboratively with clinicians, researchers, and informaticians to bring projects from concept to implementation.

Awards and Honors

While Dr. Taliercio’s profile highlights a range of accomplishments, formal details on specific research awards or honors are not explicitly listed. However, her leadership roles and appointments—such as Assistant Professor, Co-director of the NF and TSC clinics, and Associate Program Director—reflect strong recognition by her institution and peers. Additionally, her international career trajectory, moving from national public health leadership in Argentina to academic medicine in the United States, speaks to her professional reputation and the trust placed in her abilities. Her contributions to national guidelines on Hansen’s Disease in Argentina and her involvement in major research projects in dermatology and informatics show that she is regarded as a valuable collaborator and leader in her fields. Documenting formal research awards, grants, or recognitions in future applications would further strengthen this section.

Conclusion

In summary, Dr. Vanina Taliercio is a dedicated and accomplished physician-scientist who has made significant contributions across multiple disciplines, including dermatology, genetics, pediatrics, and biomedical informatics. Her career is marked by a unique combination of clinical service, research productivity, and academic leadership. She has consistently demonstrated a commitment to improving patient care, advancing medical knowledge, and mentoring students and trainees. While her profile would benefit from additional emphasis on independent research leadership and formal recognitions, she is clearly a rising figure in her field with the potential for even greater impact. Dr. Taliercio is a strong candidate for research-focused awards and honors, reflecting her broad expertise, international experience, and dedication to translational medicine. Continued pursuit of large-scale research projects, funding opportunities, and international collaborations will further enhance her academic and professional profile.

Publications Top Notes

  • Title: Worth the Effort: Lessons for Discovery and Care From an Unusual Case of Gorlin Syndrome
    Journal: American Journal of Medical Genetics Part A
    Date: 2025-05-03
    DOI: 10.1002/ajmg.a.64108
    Contributors: V. Taliercio; J. Zhao; S. E. Boyden; R. Mao; P. Bayrak‐Toydemir; A. Pflaum; J. Palumbos; A. Andrews; E. E. Baldwin; C. Welt et al.

  • Title: Quality of Life Among Family of Patients with Atopic Dermatitis and Psoriasis
    Journal: International Journal of Behavioral Medicine
    Date: 2023-06
    DOI: 10.1007/s12529-022-10104-7
    Contributors: Ashley M. Snyder; Adelheid U. Brandenberger; Vanina L. Taliercio; Bianca E. Rich; Lisa B. Webber; Abram P. Beshay; Joshua E. Biber; Rachel Hess; Jamie L. W. Rhoads; Aaron M. Secrest

  • Title: Effects of Pain From Atopic Dermatitis: Interview and Focus Group Study With Patients and Their Families
    Journal: JMIR Dermatology
    Date: 2021-10-04
    DOI: 10.2196/29826
    Contributors: Ashley M. Snyder; Vanina L. Taliercio; Adelheid U. Brandenberger; Bianca E. Rich; Lisa B. Webber; Abram P. Beshay; Joshua E. Biber; Rachel Hess; Jamie L. W. Rhoads; Aaron M. Secrest

  • Title: Effects of Pain From Atopic Dermatitis: Interview and Focus Group Study With Patients and Their Families (Preprint)
    Date: 2021-04-22
    DOI: 10.2196/preprints.29826
    Contributors: Ashley M. Snyder; Vanina L. Taliercio; Adelheid U. Brandenberger; Bianca E. Rich; Lisa B. Webber; Abram P. Beshay; Joshua E. Biber; Rachel Hess; Jamie L. W. Rhoads; Aaron M. Secrest

Risa Yamada | Health Professions | Best Researcher Award

Posted on by Shen Awards

Ms. Risa Yamada | Health Professions | Best Researcher Award

Researcher from National Center of Neurology and Psychiatry, Japan

Risa Yamada is an esteemed Chief Researcher at the Department of Preventive Intervention for Psychiatric Disorders, National Institute of Mental Health, National Center of Neurology and Psychiatry, Japan. Her research primarily focuses on neuropsychopharmacology, epidemiology, and neurophysiology in patients with psychiatric disorders such as schizophrenia, mood disorders, and substance abuse. She is renowned for her pioneering work in the epidemiology of gambling disorders, exploring the impact of comorbid behavioral addiction. Her research has yielded significant insights into the effectiveness of serotonin-5-HT1A receptor partial agonists for cognitive enhancement in schizophrenia, with findings published in prestigious journals. Additionally, she is conducting cutting-edge research on transcranial photobiomodulation to ameliorate cognitive deficits in schizophrenia. Yamada has made notable contributions to the understanding of depression severity and the role of adverse childhood experiences in mood disorders. With a background in clinical psychology and neuropsychopharmacology, she is a rising leader in the field of psychiatric research.

Professional Profile

Education

Risa Yamada completed her medical education at the Jikei University School of Medicine, earning her Ph.D. in February 2023. Prior to this, she received a Bachelor of Science degree from Toho University in 2011 and a Master of Psychology from Teikyo University in 2018. Throughout her educational journey, she focused on the intersection of clinical psychology and psychiatry, particularly in understanding the neuropsychological aspects of psychiatric disorders. Her academic development laid a strong foundation for her subsequent research career. In addition to her medical degrees, Yamada holds certifications as a Clinical Psychologist (2019) and a Public Psychologist (2019), which further demonstrate her expertise and commitment to advancing psychological and psychiatric research. These educational qualifications, coupled with her practical research experience, allow Yamada to contribute significantly to the development of new treatment strategies for psychiatric conditions, particularly those related to cognitive dysfunction and behavioral addictions.

Professional Experience

Risa Yamada currently serves as the Chief Researcher at the Department of Preventive Intervention for Psychiatric Disorders at the National Institute of Mental Health, part of the National Center of Neurology and Psychiatry in Tokyo, Japan. She has been in this role since September 2021 and has been instrumental in leading research focused on cognitive impairments in psychiatric conditions such as schizophrenia. Yamada’s career began as a Research Associate in the Department of Mental Disorder Research at the National Center of Neurology and Psychiatry from 2018 to 2021, where she investigated depression severity and its links to adverse childhood experiences and coping styles. Prior to her current position, she conducted a doctoral research project at Jikei University, where she explored the relationship between gambling disorder and psychiatric conditions. Her extensive experience spans multiple research settings, with her work having a significant impact on clinical understanding and treatment development for various psychiatric conditions. Yamada’s role as a researcher and educator also extends to her involvement in several leading academic societies in psychiatry and neuropsychopharmacology.

Research Interests

Risa Yamada’s research interests lie at the intersection of clinical psychology, psychiatry, and neuropsychopharmacology. She is deeply engaged in studying the cognitive and neurophysiological aspects of psychiatric disorders, particularly schizophrenia, mood disorders, and behavioral addictions such as gambling disorders. Her work focuses on the use of neuropsychological methods to explore the biological and psychological underpinnings of these conditions, with a particular emphasis on cognitive impairment. One of her notable research projects involves studying the augmentation of cognitive function in schizophrenia using serotonin-5-HT1A receptor partial agonists, a promising avenue for improving psychotic symptoms and cognitive deficits. Additionally, Yamada is investigating the potential of transcranial photobiomodulation, a non-invasive brain stimulation technique, to address cognitive impairments in patients with schizophrenia. She also explores the relationship between adverse childhood experiences and mood disorders, with the goal of identifying effective biomarkers and treatments for negative valence in psychiatric conditions. Her research aims to advance both theoretical understanding and practical interventions for these prevalent and challenging mental health conditions.

Research Skills

Risa Yamada possesses a diverse and advanced skill set in clinical research, particularly in the fields of neuropsychopharmacology, epidemiology, and neurophysiology. She is proficient in conducting meta-analyses and cross-sectional studies, particularly related to psychiatric disorders and cognitive dysfunction. Her expertise in neuropsychological methods allows her to investigate complex interactions between psychological traits and psychiatric conditions. Yamada is skilled in using clinical scales and neurophysiological tools, such as skin conductivity measures, to assess psychological traits like interoception and alexithymia in relation to psychiatric conditions. Furthermore, she has experience in neuroimaging techniques, including the use of transcranial photobiomodulation for brain stimulation. Yamada’s work with behavioral addiction, particularly gambling disorders, demonstrates her ability to apply epidemiological methods to mental health research. She is also adept at analyzing large-scale clinical data sets and using statistical models to explore the relationship between psychiatric symptoms and demographic variables. These research skills enable her to lead impactful studies that contribute both to the scientific community and to practical applications in the treatment of psychiatric disorders.

Awards and Honors

Risa Yamada has received recognition for her contributions to psychiatric research, particularly in the areas of neuropsychopharmacology and behavioral addiction. She has been awarded several academic honors, including recognition for her groundbreaking research on gambling disorders, which was the first of its kind in Japan. Her work on cognitive enhancement therapies for schizophrenia has been published in high-impact journals, earning her a reputation as a leader in the field. While she has not yet received large-scale awards, her growing recognition within the academic community and her role as Chief Researcher at the National Institute of Mental Health reflect her increasing influence. Yamada’s contributions to psychiatric research have been acknowledged through invitations to present her findings at prestigious international conferences. She is also a member of several leading professional societies, including the Collegium Internationale Neuro-Psychopharmacologicum and the Japanese Society of Neuropsychopharmacology, further solidifying her status as a respected researcher.

Conclusion

Risa Yamada is a highly promising and accomplished researcher in the field of psychiatry, with a focus on neuropsychopharmacology, neurophysiology, and epidemiology. Her work has already made a significant impact, particularly in the understanding of cognitive dysfunction in schizophrenia and gambling disorders. With a robust educational background and extensive professional experience, Yamada is well-positioned to continue contributing to the advancement of psychiatric research. Her innovative approach to non-invasive brain stimulation, alongside her focus on biomarkers for psychiatric conditions, highlights her potential for further breakthroughs. While her research is primarily centered on schizophrenia and mood disorders, expanding her focus to other psychiatric conditions would enhance the breadth of her contributions. With continued growth in international collaboration and further emphasis on translational research, Yamada has the potential to make a lasting impact on both clinical practice and scientific understanding in the field of psychiatry.

Publications Top Notes

  • Clinical Significance of Psychiatric Comorbidities Among Outpatients With Gambling Disorder in Japan: A 12-Month Follow-Up Study
    Authors: Yamada, R., Stickley, A., Shigeta, M., Miyata, H.
    Year: 2025

  • Semantic memory disorganization linked to social functioning in patients with schizophrenia
    Authors: Wada, A., Sumiyoshi, C., Yoshimura, N., Hashimoto, R., Matsumoto, J., Stickley, A., Yamada, Y., Kikuchi, A., Kubota, R., Matsui, M., Nakachi, K., Fujimaki, C., Adachi, L., Yamada, R., Sumiyoshi, T.
    Year: 2025

  • Autistic trait severity in early schizophrenia: Role in subjective quality of life and social functioning
    Authors: Wada, A., Yamada, R., Yamada, Y., Sumiyoshi, C., Hashimoto, R., Matsumoto, J., Kikuchi, A., Kubota, R., Matsui, M., Nakachi, K., Fujimaki, C., Adachi, L., Stickley, A., Yoshimura, N., Sumiyoshi, T.
    Year: 2025

  • Problematic gambling and psychotic-like experiences: Findings from Japan
    Authors: Stickley, A., Shirama, A., Yamada, R., Sumiyoshi, T.
    Year: 2024

  • Augmentation therapy with serotonin1A receptor partial agonists on neurocognitive function in schizophrenia: A systematic review and meta-analysis
    Authors: Yamada, R., Wada, A., Stickley, A., Yokoi, Y., Sumiyoshi, T.
    Year: 2023

  • Effect of 5-HT1A Receptor Partial Agonists of the Azapirone Class as an Add-On Therapy on Psychopathology and Cognition in Schizophrenia: A Systematic Review and Meta-Analysis
    Authors: Yamada, R., Wada, A., Stickley, A., Yokoi, Y., Sumiyoshi, T.
    Year: 2023

  • Prevalence and Clinical Significance of Psychiatric Comorbidities With Gambling Disorder in 12 Clinical Settings in Japan
    Authors: Yamada, R., Miyashita, K., Hashimoto, T. M., et al.
    Year: 2023

  • Discrepancy between Clinician-rated and Self-reported Depression Severity is Associated with Adverse Childhood Experience, Autistic-like Traits, and Coping Styles in Mood Disorders
    Authors: Yamada, R., Fujii, T., Hattori, K., et al.
    Year: 2023

  • The relationship between severity of drug problems and perceived interdependence of drug use and sexual intercourse among adult males in drug addiction rehabilitation centers in Japan
    Authors: Yamada, R., Shimane, T., Kondo, A., Yonezawa, M., Matsumoto, T.
    Year: 2021

Shoubhik Chakraborty | Health Professions | Best Researcher Award

Posted on by Shen Awards

Dr. Shoubhik Chakraborty | Health Professions | Best Researcher Award

Pediatric optometrist from Kalinga Institute of Medical Science, India

Shoubhik Chakraborty is a committed and dynamic professional in the field of Clinical Optometry, specializing in Pediatric Optometry, Binocular Vision, and Cerebral Visual Impairment (CVI). He holds a Bachelor’s degree in Clinical Optometry and Vision Science from NSHM College of Management and Technology, affiliated with MAKAUT. His professional journey is marked by practical clinical experience and a keen interest in advanced vision therapy. Shoubhik has worked with prestigious institutions like Narayana Nethralaya, AIIMS Jodhpur, and currently serves as a Pediatric Optometrist at KIMS, Bhubaneswar. He has demonstrated his research capabilities through multiple scientific publications in peer-reviewed journals. Throughout his career, he has attended major optometry conferences, reflecting his commitment to professional development and learning. With a blend of strong clinical acumen, research enthusiasm, and a drive for innovation in optometry, Shoubhik is poised to contribute meaningfully to the advancement of pediatric vision care. His passion for restoring and enhancing vision, especially among children and individuals with neurological visual impairments, is evident in both his clinical work and academic pursuits. He brings a mix of leadership, creativity, and critical thinking to every assignment, showing potential for further academic and clinical excellence.

Professional Profile

Education

Shoubhik Chakraborty’s educational background showcases a strong foundation in optometry and vision science. He completed his secondary education at Sagardighi Thermal Power School (2014–2015) under the West Bengal Board of Secondary Education (WBBSE) and his higher secondary studies at Karaiya High School (2015–2017) affiliated with the West Bengal Council of Higher Secondary Education (WBCHSE). Building on his early academic success, he pursued a Bachelor’s degree in Clinical Optometry and Vision Science (2017–2021) at NSHM College of Management and Technology, under MAKAUT. During his academic years, he completed vocational training at Susrut Eye Foundation and Research Centre, Kolkata, and undertook a comprehensive internship at MGM Eye Institute, Raipur, Chhattisgarh. Recognizing the importance of specialized training, Shoubhik further pursued a Fellowship in Pediatric Optometry, Binocular Vision, and Cerebral Visual Impairment from Narayana Nethralaya, Bangalore, which he completed between August 2021 and January 2023. His academic background has been complemented by seminars, workshops, and continuous learning in vision therapy and neuro-optometry, equipping him with the latest techniques and research-based practices in his field.

Professional Experience

Shoubhik Chakraborty’s professional journey reflects a strong commitment to clinical excellence and research-oriented optometry practice. After completing his Bachelor’s degree and internship, he pursued a Fellowship at Narayana Nethralaya, Bangalore, specializing in Pediatric Optometry, Binocular Vision, and Cerebral Visual Impairment. Post-fellowship, Shoubhik worked as a Cerebral Visual Impairment Specialist at the prestigious All India Institute of Medical Sciences (AIIMS), Jodhpur, from February 2023 to August 2023. His role at AIIMS involved specialized diagnosis, management, and vision therapy for children with complex neurological visual disorders. Currently, he is employed as a Pediatric Optometrist at KIMS, Bhubaneswar, where he continues to apply and expand his clinical and research expertise. His clinical practice integrates evidence-based methods for treating amblyopia, strabismus, and CVI, and he remains actively involved in patient-centered therapy programs. Shoubhik’s career also includes participation in national conferences, presenting his findings and staying updated with the latest advancements in pediatric and behavioral optometry. His hands-on experience across multiple renowned institutions, combined with research activities and a focus on clinical innovation, positions him as a promising healthcare professional with aspirations for greater leadership in optometry and vision research.

Research Interests

Shoubhik Chakraborty’s research interests center around Pediatric Optometry, Binocular Vision Anomalies, Cerebral Visual Impairment (CVI), Amblyopia Management, and Behavioral Optometry. He is particularly passionate about advancing the understanding of vision therapy and its long-term effects on children with neurological visual impairments. His work focuses on the development and validation of customized vision therapy programs aimed at improving binocular function, stereopsis, and visual acuity in children and young adults. He is also interested in studying the outcomes of early intervention therapies for amblyopia, anisometropia, and CVI, and their impact on patients’ overall quality of life. Shoubhik actively explores neuroplasticity and rehabilitation strategies to help children with brain injuries or developmental delays regain visual function. His goal is to bridge clinical practice and research by developing standardized protocols for vision therapy and contributing to evidence-based pediatric optometry. Furthermore, he is keen on future research collaborations that integrate neuro-optometric rehabilitation with technological innovations such as digital therapies and telehealth models to expand access to specialized vision care services.

Research Skills

Shoubhik Chakraborty possesses a wide range of research and clinical skills critical to his specialization. His research competencies include designing and executing clinical studies, performing statistical analysis of therapy outcomes, critical literature review, and drafting manuscripts for peer-reviewed publication. In clinical practice, he is skilled in the assessment and management of binocular vision disorders, orthoptic evaluations, pediatric visual development assessments, and neuro-optometric rehabilitation for CVI patients. Shoubhik also demonstrates proficiency in customized vision therapy techniques, including anti-suppression therapy, vergence therapy, and accommodative facility enhancement. His training has equipped him with the ability to critically analyze therapy outcomes and continuously refine intervention strategies. He has excellent skills in decision-making, critical thinking, creativity, teamwork, and leadership, which are crucial for multidisciplinary collaboration in clinical research settings. He also holds a diploma in computer applications, enabling him to efficiently manage patient data, conduct research documentation, and prepare presentations. Shoubhik’s ability to merge research rigor with clinical sensitivity makes him well-suited for future roles involving innovation in pediatric optometry and vision science.

Awards and Honors

Shoubhik Chakraborty’s academic and professional journey has been marked by notable achievements and recognitions. His most significant honors come through his contributions to scientific publications in reputed optometry journals. His case study on restoring binocular vision in a 23-year-old myopic anisometropic amblyopia patient was published in Optometry and Visual Performance (October 2023). His retrospective study on the outcomes of vision therapy among children with Cerebral Visual Impairment was also accepted and published in Optometry and Visual Performance (March 2024). Furthermore, his research on the impact of active vision therapy on anisometropic amblyopia cases was published in EC Ophthalmology (September 2024). Beyond publishing, his participation in national-level conferences like the Asia Pacific Optometry Summit, Bengal Optometry Conference, Kolkata Optometry Conference, and Karnataka Optometry Conference demonstrates his active engagement in the professional community. His Fellowship in Pediatric Optometry and Cerebral Visual Impairment from Narayana Nethralaya is another key milestone that highlights his commitment to clinical and academic excellence. These achievements position him as a promising young optometrist with potential for greater recognition and leadership in vision science.

Conclusion

In conclusion, Shoubhik Chakraborty is a highly motivated and emerging professional in the field of optometry, showing commendable progress in both clinical practice and research. His educational background, fellowship training, and hands-on experience with specialized populations such as children with Cerebral Visual Impairment underline his dedication to advancing pediatric vision care. His publications in peer-reviewed journals demonstrate his ability to contribute meaningful research to the field. With strong clinical skills, research acumen, leadership qualities, and a commitment to continuous learning, Shoubhik is well-positioned to make significant contributions to pediatric optometry and vision therapy research. To further strengthen his professional trajectory, he could consider expanding his research portfolio through multicenter studies and pursuing advanced degrees such as a Master’s or Ph.D. Overall, Shoubhik embodies the qualities of a future leader in clinical optometry and research, and he is well-deserving of encouragement and support for higher academic and professional achievements.

Publications Top Notes

  • Recovering Vision and Binocularity in a Presbyopic Patient with Amblyopia
    Authors: SD Shoubhik Chakraborty, Hajira R
    Journal: VDR, Vol. 11(1), p. 48
    Year: 2025

  • Prevalence of Accommodative Insufficiency in Children With Normal Accommodative-Convergence/Accommodation Ratio and Its Association With Refractive Error: A Cross-Sectional Study
    Authors: S Chakraborty, S Parida, SK Mohanty, M Das, S Dash, S Mohanty
    Journal: Cureus, Vol. 17(2)
    Year: 2025

  • The Role of Vision Therapy in the Management of Recurrent Hordeolum
    Authors: S Chakraborty, PP Sahu, SK Mohanty, R Hajira
    Year: 2025

  • Treatment of Anisometropic Amblyopia Using a Combination Approach
    Authors: HR Shoubhik Chakraborty, Shrutakirty Parida
    Journal: VDR, Vol. 10(4), p. 187
    Year: 2024

  • The Impact of Active Vision Therapy on Vision and Binocularity for Anisometropic Amblyopia Cases
    Authors: SR Shoubhik Chakraborty, Shrutakirty Parida, Sahanaz Hossain
    Journal: EC Ophthalmology
    Year: 2024

  • Outcomes Of Vision Therapy Among Children with Cerebral Visual Impairment: A Retrospective Study
    Authors: S Chakraborty, P Sarbajna, A Vinekar, B Shetty
    Journal: Optometry & Visual Performance, Vol. 12(1)
    Year: 2024

  • Case Report: Enhancing Binocular Vision of an Adult with Anisometropic Amblyopia
    Authors: S Chakraborty, P Sarbajna, A Vinekar, B Shetty
    Journal: Optometry & Visual Performance, Vol. 11(3)
    Year: 2023

  • Treatment of Anisometropic Amblyopia Using a Combination Approach (Duplicate Title)
    Authors: S Chakraborty, B Optom, S Parida, R Hajira

  • Let’s Delve Into the Least Explored Visual Pathway
    Author: S Chakraborty

Xia Chen | Medicine and Dentistry | Best Researcher Award

Posted on by Shen Awards

Ms. Xia Chen | Medicine and Dentistry |  Best Researcher Award

Professor from Yunnan Provincial Hospital of Chinese Medicine, China

Xia Chen is an accomplished chief physician, professor, and master’s supervisor, specializing in integrated Chinese and Western medicine, particularly in gastroenterology. Born in 1978 in Yunnan, China, she has devoted more than two decades to clinical practice, teaching, and scientific research. Currently, she serves as the leader of the Department of Gastroenterology of Traditional Chinese Medicine at Yunnan Provincial Hospital of Chinese Medicine. She has gained recognition as an Outstanding Young Practitioner of Chinese Medicine in Yunnan Province and holds membership in the Hepatobiliary Disease Branch of the Chinese Medical Association. Her career focuses on the diagnosis and treatment of digestive diseases using both traditional Chinese medicine and Western medicine approaches. Xia Chen’s contribution extends beyond clinical work to research projects, drug trials, and academic publishing. Her ability to bridge traditional and modern medical practices has made her a notable figure in her field. Over the years, she has led and participated in numerous prestigious research projects and has authored or co-authored several scholarly works. Xia Chen’s career reflects dedication to improving healthcare outcomes through integrated medicine and advancing research in digestive health, making her a leader in her specialty and an inspiration for future researchers and clinicians.

Professional Profile

Education

Although detailed information about Xia Chen’s educational background is not explicitly provided, her current standing as a chief physician and professor suggests a comprehensive academic journey in medicine, likely beginning with a bachelor’s degree in traditional Chinese medicine or clinical medicine. Following her undergraduate studies, it is plausible she pursued further specialization, completing advanced degrees, possibly a master’s degree or doctorate, focusing on integrated Chinese and Western medicine with a specialty in digestive diseases. Xia Chen’s position as a master’s supervisor also indicates her formal academic qualification aligns with national standards for academic leadership roles in China, which typically require at least a master’s degree combined with significant clinical expertise. Her education would have provided her a strong foundation in traditional Chinese medical principles, combined with extensive training in modern clinical practices, pharmacology, and research methodology. Given her leadership in research projects and teaching, she likely continued her professional development through certifications, clinical fellowships, and continuous medical education programs. Her educational journey underpins her expertise in gastroenterology and serves as the backbone for her clinical, academic, and research excellence.

Professional Experience

Xia Chen has built a remarkable professional career, accumulating over 20 years of experience in clinical practice, teaching, and research in the field of integrated Chinese and Western medicine. She currently serves as the leader of the Department of Gastroenterology of Traditional Chinese Medicine at Yunnan Provincial Hospital of Chinese Medicine. Her daily responsibilities include diagnosing and treating patients with complex digestive diseases, mentoring master’s students, and overseeing research activities. She has established herself as a specialist who skillfully combines traditional Chinese medical therapies with modern Western treatments, offering holistic and effective patient care. Xia Chen’s leadership extends to supervising clinical trials and participating in national Phase II, III, and IV drug research studies. Her practical skills are complemented by her academic contributions, which include teaching future healthcare professionals and guiding research initiatives. Furthermore, she actively contributes to healthcare policy improvements through her roles in professional associations such as the Hepatobiliary Disease Branch of the Chinese Medical Association. Her professional experience highlights her comprehensive expertise across clinical, academic, and scientific domains, making her a pivotal figure in advancing the integration of traditional Chinese medicine with contemporary medical science.

Research Interests

Xia Chen’s research interests focus on the integration of traditional Chinese medicine and Western medicine approaches to digestive diseases. A significant part of her work explores the therapeutic effects of natural medicines on intestinal dynamics. Her research aims to scientifically validate the efficacy of traditional remedies and their mechanisms of action, thereby bridging the gap between ancient practices and modern clinical science. Additionally, Xia Chen is deeply interested in clinical trials related to new drug developments, having participated in numerous national Phase II, III, and IV studies. Her research spans studying gastrointestinal motility disorders, chronic digestive conditions, and hepatobiliary diseases. She is particularly motivated by the desire to develop more effective, less invasive, and side-effect-minimized treatments through integrative approaches. Another important research area for Xia Chen is understanding how traditional Chinese formulations can complement or enhance the effects of Western pharmacological interventions. Her research is highly practical, patient-centered, and innovative, targeting improvements in clinical outcomes. With a growing emphasis on evidence-based medicine, her work contributes significantly to validating and modernizing traditional Chinese medicinal practices while maintaining their historical integrity and therapeutic richness.

Research Skills

Xia Chen possesses a broad range of research skills that have been instrumental in her professional success. She demonstrates expertise in designing and conducting clinical trials, especially those combining traditional Chinese medicinal approaches with Western methodologies. Her skill set includes protocol development, patient recruitment and management, data analysis, and reporting in accordance with national and international standards. She is proficient in evaluating the pharmacological effects of natural medicines and their applications in digestive health. Xia Chen’s publication record highlights her ability to carry out longitudinal studies and synthesize findings for publication in peer-reviewed journals. Her role as a master’s supervisor also reflects her ability to guide young researchers in research design, methodology, and thesis writing. Furthermore, her participation in over ten national drug studies indicates advanced skills in regulatory compliance, clinical pharmacology, and interdisciplinary collaboration. Xia Chen’s integrated approach to traditional and modern research paradigms exemplifies her unique strengths. Her research methodology is thorough, combining qualitative insights from traditional Chinese medicine with the quantitative rigor required in modern clinical research. These combined skills make her a formidable researcher capable of making impactful contributions to the field.

Awards and Honors

Throughout her distinguished career, Xia Chen has received notable awards and honors recognizing her professional and academic contributions. She has been named an Outstanding Young Practitioner of Chinese Medicine in Yunnan Province, an accolade that underscores her clinical excellence, research innovation, and contributions to the advancement of traditional Chinese medicine. Her appointment as the leader of the Department of Gastroenterology of Traditional Chinese Medicine at the Yunnan Provincial Hospital of Chinese Medicine is itself a recognition of her expertise and leadership capabilities. Furthermore, her active membership in the Hepatobiliary Disease Branch of the Chinese Medical Association reflects national recognition of her skills and knowledge. These honors highlight her respected position within the Chinese medical community. They also affirm her commitment to bridging traditional Chinese medicine with modern clinical practices. While specific awards for research publications or international recognition have not been detailed, her extensive leadership in research projects and contribution to multiple monographs reinforce her academic and professional stature. Xia Chen’s awards and honors validate her significant and ongoing impact in the field of integrated medicine and gastroenterology.

Conclusion

Xia Chen is a highly accomplished clinician, educator, and researcher whose career embodies excellence in integrating traditional Chinese and Western medical practices. Her dedication to advancing digestive health through innovative, interdisciplinary methods sets her apart as a leader in her field. With over two decades of professional experience, leadership in major research projects, and numerous scholarly contributions, she has significantly impacted both clinical practice and academic research. Her recognition as an Outstanding Young Practitioner of Chinese Medicine and leadership roles within national medical organizations reflect her esteemed reputation. While opportunities exist for expanding her international research presence, Xia Chen’s current achievements already demonstrate her remarkable expertise, commitment, and influence. She serves as a bridge between ancient medical wisdom and contemporary science, promoting holistic and evidence-based healthcare solutions. As she continues to build on her impressive body of work, Xia Chen is poised to make even greater contributions to global medical science, ensuring that traditional Chinese medicine remains relevant, respected, and scientifically validated in the modern era.

Publications Top Notes

  • Title: Quercetin Inhibits Cardiomyocyte Apoptosis via Sirt3/SOD2/Mitochondrial Reactive Oxygen Species During Myocardial Ischemia–Reperfusion Injury

  • Authors: Xiong Da, Wang Xin, Wang Haiyu, Zhao Zicong, Ren Wenjun

  • Year: 2024

  • Citations: 6

Stephen Twumasi | Medicine and Dentistry | Best Researcher Award

Posted on by Shen Awards

Mr. Stephen Twumasi | Medicine and Dentistry | Best Researcher Award

Kwame Nkrumah University of Science and Technology, Ghana

Stephen Twumasi is an emerging biomedical researcher with a strong academic background in haematology and medical diagnostics. His academic and professional pursuits have been shaped by a passion for understanding the molecular and immunological mechanisms underlying human diseases, particularly in the context of cancer, infectious diseases, and hematological disorders. With an M.Phil. in Haematology from Kwame Nkrumah University of Science and Technology (KNUST), Ghana, and a B.Sc. in Medical Laboratory Science from the University of Cape Coast, he has demonstrated academic rigor and a deep interest in advancing health research. Stephen has actively pursued professional development through short courses in genomics, bioinformatics, systematic reviews, and community health entrepreneurship. His current research focuses on tumor immunology, developmental hematopoiesis, and molecular diagnostics for chronic and infectious diseases. Despite being in the early stages of his research career, he is keenly aware of the global health landscape and has aligned his work with critical health issues affecting Africa and beyond. With aspirations to make a meaningful contribution to global health research, Stephen combines his academic strength with continuous skill enhancement and a commitment to multidisciplinary inquiry.

Professional Profile

Education

Stephen Twumasi’s academic journey reflects a consistent focus on biomedical sciences and a deepening specialization in haematology. He earned his M.Phil. in Haematology from the Kwame Nkrumah University of Science and Technology (KNUST), Kumasi, Ghana, in 2024. With a cumulative weighted average of 69.40/100 (equivalent to a CGPA of 3.8/4.0) and a thesis graded ‘A’ (Pass), he displayed academic excellence and research capability in the program. Prior to his postgraduate studies, he obtained a Bachelor of Science in Medical Laboratory Science from the University of Cape Coast in 2020, graduating with a Second Class Honors (Upper Division) and a CGPA of 3.2/4.0. His foundational education began at Adventist Senior High School in Kumasi, where he completed his West Africa Senior School Certificate Examination (WASSCE) in 2015. In addition to formal education, Stephen has completed several short courses to broaden his knowledge and research skills. These include certifications in Genomics and Bioinformatics, Systematic Review and Meta-analyses, Research Writing for Publication, One Health Basics, and Community Health Entrepreneurship. His commitment to lifelong learning and interdisciplinary training places him in a strong position for advanced research and academic engagement.

Professional Experience

Stephen Twumasi’s professional experience is grounded in his academic training in medical diagnostics and laboratory science. While specific employment roles have not been listed, it is evident that his academic journey included substantial practical exposure and laboratory-based research, particularly during his M.Phil. studies in Haematology. His postgraduate thesis work required advanced skills in diagnostic hematology, interpretation of immunological markers, and laboratory-based experimentation, reflecting real-world clinical and research competence. Through his involvement in academic programs and training workshops, Stephen has gained experience in handling molecular biology protocols, data analysis, and diagnostic procedures that are critical in modern healthcare settings. His training in community health entrepreneurship also suggests a practical understanding of the healthcare ecosystem and how scientific research can be translated into community impact. Stephen’s practical experience is further enhanced by his completion of skill-based short courses offered by reputable institutions and international collaborators. These programs have allowed him to interact with health researchers across Africa and beyond, enriching his perspectives and research readiness. Though his formal professional roles may still be developing, Stephen has built a strong foundation in biomedical practice and research through hands-on learning and academic immersion.

Research Interest

Stephen Twumasi’s research interests are firmly anchored in immunology, hematology, and molecular diagnostics, with a multidisciplinary approach that reflects current global biomedical priorities. He is particularly interested in understanding the immunological and molecular changes that occur within the tumor microenvironment and how these changes influence cancer progression, therapeutic response, and disease outcome. His interest also extends to developmental hematopoiesis and the molecular mechanisms that underlie blood cell formation, which are critical in understanding both normal physiology and disease pathology. Stephen aims to explore immunological and molecular cell alterations in age-related and inflammatory diseases, such as autoimmune disorders, chronic infections, and degenerative conditions. A significant portion of his research is directed at identifying early diagnostic biomarkers for diseases prevalent in sub-Saharan Africa, including HIV/AIDS, tuberculosis, sickle cell disease, diabetes, and kidney disease. This demonstrates his commitment to applied biomedical research that has direct implications for public health and clinical practice. By focusing on early detection and molecular profiling, Stephen envisions contributing to the development of cost-effective and scalable diagnostic tools. His research orientation is not only academically relevant but also aligned with global health equity and the fight against non-communicable and infectious diseases.

Research Skills

Stephen Twumasi has developed a strong portfolio of research skills that align with modern biomedical research demands. His training in haematology and molecular biology equips him with the ability to conduct detailed laboratory analyses and interpret complex immunological data. He is proficient in diagnostic techniques related to blood disorders and has applied this expertise during his thesis research and laboratory coursework. His skills extend into bioinformatics and genomics, where he has gained practical knowledge through certified training programs. Stephen is also trained in systematic reviews and meta-analysis, enabling him to conduct high-level literature synthesis and evidence-based assessments. His familiarity with research writing and publication, gained through specialized workshops, enhances his ability to produce and disseminate scientific findings effectively. Stephen is knowledgeable in One Health approaches, showing his capacity to conduct interdisciplinary research that bridges human, animal, and environmental health. His training in community health entrepreneurship complements his scientific skills by adding a dimension of translational research and innovation. Overall, Stephen possesses a diverse set of skills—ranging from laboratory diagnostics to scientific writing and data interpretation—that prepare him for successful academic research and collaborative scientific work.

Awards and Honors

While there are no specific awards or honors listed in Stephen Twumasi’s current profile, his academic achievements and certifications reflect commendable performance and initiative. His excellent academic record, especially his strong performance in the M.Phil. Haematology program at KNUST, suggests merit-worthy scholarly effort. His pursuit of numerous competitive and high-impact short courses—offered by organizations such as the German-West Africa Center for Global Health, MasterCard Foundation, and Genomac Institute—also highlights his selection into esteemed training programs. These certifications are often reserved for promising young researchers who demonstrate a commitment to academic and research excellence. In addition, Stephen has shown proactive engagement in international and interdisciplinary learning environments, which is itself a testament to his academic motivation and research potential. As his research career progresses and he begins to publish his work and engage in more collaborative projects, he is likely to attract competitive fellowships, grants, and awards. While he may currently be at the formative stage of his academic recognition, Stephen’s trajectory and research readiness point toward future honors and distinctions as he contributes more substantively to the scientific community.

Conclusion

Stephen Twumasi is a dedicated and promising early-career researcher whose academic focus and professional development align with global health and biomedical priorities. With a robust educational foundation in haematology and medical laboratory science, complemented by strategic certifications in genomics, bioinformatics, One Health, and research writing, he has cultivated a multidisciplinary research profile. His interests in tumor immunology, hematopoiesis, and early diagnostics of infectious and chronic diseases reflect a strong commitment to improving health outcomes through science. While his formal professional roles and recognitions are still evolving, his proactive learning approach and research enthusiasm position him as a future leader in biomedical research. He has already demonstrated the capacity for scientific inquiry and critical analysis, supported by practical lab experience and theoretical understanding. With continued mentorship, opportunities for publication, and engagement in collaborative research, Stephen is well on the path to making impactful contributions to medical science and public health. He is a suitable candidate for research-focused awards and development programs, and his future holds promise as he builds on his strengths and expands his academic influence. His dedication to advancing diagnostic and molecular research makes him a valuable asset to the scientific and health communities.

Publications Top Notes

  1. Haemato‐urological profile and asymptomatic urinary tract infection in Ghanaian steady‐state sickle cell disease patients: A case‐control study
    📚 Health Science Reports
    📅 Year: 2025
    👥 Authors: Stephen Twumasi, Richard Owusu Ansah, Samuel Essien‐Baidoo, Laud Anthony W. Basing, Alexander Yaw Debrah, Enoch Odame Anto, Allwell Adofo Ayirebi, Rebecca Asiamah‐Broni, Waldemer Attivor, Eric Twum Ameyaw, et al.
    📈 Citations: Not available yet

  2. Assessing liver and iron markers in steady state paediatric SCD patients to ascertain the hepatic consequences of haemotransfusion: A case-control study in Ghana
    📄 Preprint
    📅 Year: 2024
    👥 Authors: John Agyemang Sah, Benedict Sackey, Enoch Odame Anto, Allwell Adofo Ayirebi, Stephen Twumasi, Richard Vikpebah Duneeh, Ebenezer Senu, Veronica Barnor, David Boakye, Daniel Nii Martey Antonio, et al.

  3. Haemato-urological profile and asymptomatic urinary tract infection in Ghanaian steady-state sickle cell disease patients
    📄 Preprint
    📅 Year: 2024
    👥 Authors: Stephen Twumasi, Richard Owusu Ansah, Samuel Essien-Baidoo, Laud Anthony W. Basing, Alexander Yaw Debrah, Enoch Odame Anto, Allwell Adofo Ayirebi, Rebecca Asiamah-Broni, Waldemer Attivor, Eric Twum Ameyaw, et al.

  4. Diagnostic value of neutrophil gelatinase-associated lipocalin and neutrophil-to-lymphocyte ratio in type 2 diabetes mellitus individuals with reduced estimated glomerular filtration rate (eGFR): A case-control study in a municipal hospital in Ghana
    📄 Preprint
    📅 Year: 2024
    👥 Authors: Allwell Adofo Ayirebi, Wina Ivy Ofori Boadu, Benedict Sackey, Lilian Antwi-Boateng, Prince Adoba, Patrick Adu, Joseph Boachie, Stephen Twumasi, Joseph Frimpong, Emmanuel Ekow Korsah, et al.

  5. Neutrophil gelatinase-associated lipocalin and fibrinogen-to-albumin ratio are indicators of nephropathy in adult steady state sickle cell disease patients: A multicenter case-control study in Ghana
    📄 Preprint
    📅 Year: 2024
    👥 Authors: Stephen Twumasi, Enoch Odame Anto, Christian Obirikorang, Richard Kobina Dadzie Ephraim, Benedict Sackey, Vivian Paintsil, Richard Owusu Ansah, Alfred Effah, Allwell Adofo Ayirebi, Angela Opoku, et al.